JP2018519834A5 - - Google Patents

Download PDF

Info

Publication number
JP2018519834A5
JP2018519834A5 JP2018500473A JP2018500473A JP2018519834A5 JP 2018519834 A5 JP2018519834 A5 JP 2018519834A5 JP 2018500473 A JP2018500473 A JP 2018500473A JP 2018500473 A JP2018500473 A JP 2018500473A JP 2018519834 A5 JP2018519834 A5 JP 2018519834A5
Authority
JP
Japan
Prior art keywords
syndrome
disease
autoimmune
tailpiece
granulomatosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500473A
Other languages
English (en)
Japanese (ja)
Other versions
JP7097293B2 (ja
JP2018519834A (ja
Filing date
Publication date
Priority claimed from GBGB1511787.2A external-priority patent/GB201511787D0/en
Application filed filed Critical
Publication of JP2018519834A publication Critical patent/JP2018519834A/ja
Publication of JP2018519834A5 publication Critical patent/JP2018519834A5/ja
Application granted granted Critical
Publication of JP7097293B2 publication Critical patent/JP7097293B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500473A 2015-07-06 2016-07-06 ヒトＦｃ受容体に結合する融合タンパク質 Expired - Fee Related JP7097293B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1511787.2 2015-07-06
GBGB1511787.2A GB201511787D0 (en) 2015-07-06 2015-07-06 Proteins
PCT/EP2016/065914 WO2017005767A1 (en) 2015-07-06 2016-07-06 Fusion proteins which bind to human fc receptors

Publications (3)

Publication Number Publication Date
JP2018519834A JP2018519834A (ja) 2018-07-26
JP2018519834A5 true JP2018519834A5 (enExample) 2021-10-28
JP7097293B2 JP7097293B2 (ja) 2022-07-07

Family

ID=54013529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018500473A Expired - Fee Related JP7097293B2 (ja) 2015-07-06 2016-07-06 ヒトＦｃ受容体に結合する融合タンパク質

Country Status (10)

Country Link
US (1) US20180194856A1 (enExample)
EP (1) EP3319991A1 (enExample)
JP (1) JP7097293B2 (enExample)
CN (1) CN108473571B (enExample)
AU (1) AU2016290523B2 (enExample)
BR (1) BR112017028331A2 (enExample)
CA (1) CA2991363A1 (enExample)
EA (1) EA201890225A1 (enExample)
GB (1) GB201511787D0 (enExample)
WO (1) WO2017005767A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016139006A (ru) 2014-03-05 2018-04-05 Юсб Биофарма Спрл Мультимерные fc-белки
SI3325011T1 (sl) 2015-07-24 2021-02-26 Gliknik Inc. Fuzijski proteini humanih proteinskih fragmentov za tvorbo pravilnih multimeriziranih imunoglobulin FC sestavkov s povečanim vezanjem komplementa
GB201607979D0 (en) * 2016-05-06 2016-06-22 Liverpool School Tropical Medicine Monomeric proteins and uses thereof
CA3026420A1 (en) 2016-06-07 2017-12-14 Gliknik Inc. Cysteine-optimized stradomers
SG11201900427PA (en) 2016-07-22 2019-02-27 Gliknik Inc Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor binding
IL266988B2 (en) 2016-12-09 2024-11-01 Gliknik Inc Methods of treating inflammatory disorders with multivalent fc compounds
JP7351835B2 (ja) * 2017-12-14 2023-09-27 ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト 視神経脊髄炎の処置のための組換えＩｇＧ Ｆｃ多量体
EP3765492A1 (en) * 2018-03-16 2021-01-20 Liverpool School of Tropical Medicine Chimeric fc receptor binding proteins and uses thereof
CN115724985A (zh) * 2021-08-27 2023-03-03 三生国健药业（上海）股份有限公司 一种cdc平台抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147326A1 (en) * 1996-06-14 2002-10-10 Smithkline Beecham Corporation Hexameric fusion proteins and uses therefor
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
DE10001372A1 (de) * 2000-01-14 2001-08-02 Deutsches Krebsforsch Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen
GB0922209D0 (en) * 2009-12-18 2010-02-03 Univ Nottingham Proteins, nucleic acid molecules and compositions
AU2012392760C1 (en) * 2012-10-17 2021-08-12 CSL Behring Lengnau AG Immunomodulatory proteins
EP3114137A1 (en) * 2014-03-05 2017-01-11 UCB Biopharma SPRL Multimeric fc proteins
RU2016139006A (ru) * 2014-03-05 2018-04-05 Юсб Биофарма Спрл Мультимерные fc-белки
WO2016139365A1 (en) * 2015-03-05 2016-09-09 Ucb Biopharma Sprl Polymeric fc proteins and methods of screening to alter their functional characteristics

Similar Documents

Publication Publication Date Title
JP2018527011A5 (enExample)
Dinarello et al. Treating inflammation by blocking interleukin-1 in humans
ZA202201378B (en) Anti-cd154 antibodies and uses thereof
FI3985002T3 (fi) Aryyli-, heteroaryyli- ja heterosyklisiä lääkeyhdisteitä sairauksien hoitoon
PH12016500791B1 (en) Novel amino pyrimidine derivatives
MX2014000338A (es) Derivados de pirrolo-pirimidina novedoso.
HRP20191199T1 (hr) Formulacije protutijela anti-prolaktinskog receptora
JP2017520571A5 (enExample)
JP2016503010A5 (enExample)
JP2024504366A5 (enExample)
JP2024531259A5 (enExample)
JP2013535445A5 (enExample)
JP2019509986A5 (enExample)
JP2025515191A5 (enExample)
Tanabe et al. B lymphocytes: crucial contributors to brain development and neurological diseases
JP2024542096A5 (enExample)
JP2015519355A5 (enExample)
IL277103B1 (en) IgG-stimulated remyelination of peripheral nerves
JP2024541995A5 (enExample)
JP2024546654A5 (enExample)
JP2025516364A5 (enExample)
JP2024541994A5 (enExample)
NZ747665B2 (en) Cd200 mutant and its uses
JP2022513490A5 (enExample)
Shaposhnikova et al. Possible role of adaptation mechanisms of the autonomic nervous system in gastrointestinal and urinary tract disorders in children